HKD5.19
0.38% today
Hong Kong, Nov 21, 09:00 am CET
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

CSPC Pharmaceutical Group Limited Target price 2024 - Analyst rating & recommendation

CSPC Pharmaceutical Group Limited Classifications & Recommendation:

Buy
59%
Hold
38%
Sell
3%

CSPC Pharmaceutical Group Limited Price Target

Target Price HKD6.98
Price HKD5.19
Potential
Number of Estimates 25
25 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2025 . The average CSPC Pharmaceutical Group Limited target price is HKD6.98. This is higher than the current stock price. The highest price target is
HKD11.99 131.01%
register free of charge
, the lowest is .
A rating was issued by 29 analysts: 17 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 11 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2025 of . Most analysts recommend the CSPC Pharmaceutical Group Limited stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion HKD 34.75 33.06
3.40% 4.87%
EBITDA Margin 25.80% 25.49%
1.91% 1.21%
Net Margin 18.77% 17.59%
3.50% 6.28%

27 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2024 . The average CSPC Pharmaceutical Group Limited sales estimate is

HKD33.1b
Unlock
. This is
3.47% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD35.2b 2.85%
Unlock
, the lowest is
HKD31.3b 8.59%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 HKD34.8b 3.40%
2024
HKD33.1b 4.87%
Unlock
2025
HKD33.9b 2.50%
Unlock
2026
HKD35.9b 6.06%
Unlock
2027
HKD29.4b 18.26%
Unlock
2028
HKD31.8b 8.37%
Unlock

21 Analysts have issued an CSPC Pharmaceutical Group Limited EBITDA forecast 2024. The average CSPC Pharmaceutical Group Limited EBITDA estimate is

HKD8.4b
Unlock
. This is
7.46% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD9.8b 7.88%
Unlock
, the lowest is
HKD7.6b 17.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 HKD9.0b 1.56%
2024
HKD8.4b 6.01%
Unlock
2025
HKD8.6b 2.35%
Unlock
2026
HKD9.4b 8.98%
Unlock

EBITDA Margin

2023 25.80% 1.91%
2024
25.49% 1.21%
Unlock
2025
25.46% 0.12%
Unlock
2026
26.16% 2.75%
Unlock

15 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2024. The average CSPC Pharmaceutical Group Limited net profit estimate is

HKD5.8b
Unlock
. This is
9.20% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD6.5b 0.89%
Unlock
, the lowest is
HKD4.7b 26.22%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 HKD6.5b 6.78%
2024
HKD5.8b 10.85%
Unlock
2025
HKD5.7b 1.96%
Unlock
2026
HKD6.1b 6.19%
Unlock
2027
HKD4.5b 25.22%
Unlock
2028
HKD5.2b 13.76%
Unlock

Net Margin

2023 18.77% 3.50%
2024
17.59% 6.28%
Unlock
2025
16.82% 4.38%
Unlock
2026
16.85% 0.18%
Unlock
2027
15.41% 8.55%
Unlock
2028
16.18% 5.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share HKD 0.55 0.49
6.78% 10.91%
P/E 10.63
EV/Sales 1.55

15 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

HKD0.49
Unlock
. This is
9.26% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
HKD0.54 0.00%
Unlock
, the lowest is
HKD0.40 25.93%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 HKD0.55 6.78%
2024
HKD0.49 10.91%
Unlock
2025
HKD0.48 2.04%
Unlock
2026
HKD0.51 6.25%
Unlock
2027
HKD0.38 25.49%
Unlock
2028
HKD0.43 13.16%
Unlock

P/E ratio

Current 9.62 19.09%
2024
10.63 10.50%
Unlock
2025
10.84 1.98%
Unlock
2026
10.21 5.81%
Unlock
2027
13.65 33.69%
Unlock
2028
12.00 12.09%
Unlock

Based on analysts' sales estimates for 2024, the CSPC Pharmaceutical Group Limited stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.50 24.62%
2024
1.55 3.41%
Unlock
2025
1.51 2.44%
Unlock
2026
1.43 5.71%
Unlock
2027
1.75 22.33%
Unlock
2028
1.61 7.73%
Unlock

P/S ratio

Current 1.77 22.68%
2024
1.84 3.60%
Unlock
2025
1.79 2.44%
Unlock
2026
1.69 5.71%
Unlock
2027
2.07 22.34%
Unlock
2028
1.91 7.73%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today